{"nct_id":"NCT01965613","title":"A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2014-01-31","start_date_type":"ACTUAL","primary_completion_date":"2016-12-31","primary_completion_date_type":"ACTUAL","completion_date":"2016-12-31","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}